Biotechnology Fund Financial Statements From 2010 to 2024
| RYBOX Fund | USD 66.94 1.08 1.64% |
Check Biotechnology Fund financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Biotechnology Fund's main balance sheet or income statement drivers, such as , as well as many indicators such as . Biotechnology financial statements analysis is a perfect complement when working with Biotechnology Fund Valuation or Volatility modules.
Biotechnology |
Biotechnology Fund Class Mutual Fund Price To Earning Analysis
Biotechnology Fund's Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Biotechnology Fund Price To Earning | 18.21 X |
Most of Biotechnology Fund's fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotechnology Fund Class is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
| Competition |
Based on the latest financial disclosure, Biotechnology Fund Class has a Price To Earning of 18.21 times. This is much higher than that of the Rydex Funds family and significantly higher than that of the Health category. The price to earning for all United States funds is notably lower than that of the firm.
Biotechnology Fund Class Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biotechnology Fund's current stock value. Our valuation model uses many indicators to compare Biotechnology Fund value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biotechnology Fund competition to find correlations between indicators driving Biotechnology Fund's intrinsic value. More Info.Biotechnology Fund Class is rated top fund in price to earning among similar funds. It also is rated top fund in price to book among similar funds fabricating about 0.19 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Biotechnology Fund Class is roughly 5.22 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotechnology Fund's earnings, one of the primary drivers of an investment's value.About Biotechnology Fund Financial Statements
Biotechnology Fund investors use historical fundamental indicators, such as Biotechnology Fund's revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Biotechnology Fund. Please read more on our technical analysis and fundamental analysis pages.
Under normal circumstances, the fund invests substantially all of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Fund financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Fund security.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |